secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHAMPIONS ONCOLOGY, INC. (CSBR)
CIK:        0000771856
Form:       8-K
Filed at:   2023-10-17T23:59:59+00:00
Accession:  0001628280-23-034475
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Champions Oncology appoints Brady Davis as President, effective Oct 9, 2023
---------------------------------------------------------------------------

- Brady Davis appointed President; annual base salary of $425,000 plus 50% target bonus.
- Davis receives 135,000 stock options vesting over 4 years and 7,500 vesting over 1 year.
- Davis brings 25+ years experience from Illumina, Oracle, Hewlett Packard, DNAnexus, and Canexia Health.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/771856/000162828023034475/0001628280-23-034475-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/771856/000162828023034475/csbr-20231009.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-034475

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer